New biochemical serum markers could be used to advance the diagnosis and prognosis of HBV-associated liver diseases during the progression of chronic hepatitis B into cirrhosis and hepatocellular carcinoma. Scientists determined whether the 4210 Da and 1866 Da polypeptides are serum metabolite biomarkers of hepatopathy with hepatitis B virus.
[Scientific Reports]
Sorry, but the selected Zotpress account can't be found.
